Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 3
Submit an article Journal homepage
4,393
Views
78
CrossRef citations to date
0
Altmetric
Original Research

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Axel LechnerDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany;Cologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany;Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig Maximilians University, Munich, Germany;Gene Center, Ludwig Maximilians University, Munich, GermanyView further author information
,
Hans A. SchlößerCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany;Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, GermanyView further author information
,
Martin ThelenCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany;Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, GermanyView further author information
,
Kerstin WennholdCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany;Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, GermanyView further author information
,
Sacha I. RothschildDepartment of Internal Medicine, Medical Oncology, University Hospital Basel, Basel, SwitzerlandView further author information
,
Ramona GillesInstitute of Transfusion Medicine, University of Cologne, Cologne, GermanyView further author information
,
Alexander QuaasInstitute of Pathology, University of Cologne, Cologne, GermanyView further author information
,
Oliver G. SieferJean-Uhrmacher-Institute for Clinical ENT Research, University of Cologne, Cologne, GermanyView further author information
,
Christian U. HuebbersJean-Uhrmacher-Institute for Clinical ENT Research, University of Cologne, Cologne, GermanyView further author information
,
Engin CukurogluComputational and Systems Biology, Genome Institute of Singapore, SingaporeView further author information
,
Jonathan GökeComputational and Systems Biology, Genome Institute of Singapore, Singapore;National Cancer Centre, SingaporeView further author information
,
Axel HillmerInstitute of Pathology, University of Cologne, Cologne, GermanyView further author information
,
Birgit GathofInstitute of Transfusion Medicine, University of Cologne, Cologne, GermanyView further author information
,
Moritz F. MeyerDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, GermanyView further author information
,
Jens P. KlussmannDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, GermanyView further author information
,
Alexander Shimabukuro-VornhagenCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, GermanyView further author information
,
Sebastian TheurichCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Gene Center, Ludwig Maximilians University, Munich, Germany;Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany;Cancer- and Immunometabolism Research Group, Dept. I of Internal Medicine, University Hospital Cologne, Cologne, Germany;Department of Medicine III, University Hospital, LMU Munich, GermanyView further author information
,
Dirk BeutnerDepartment of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany;Department of Otorhinolaryngology, Head and Neck Surgery, Georg August University, Goettingen, GermanyCorrespondence[email protected]
View further author information
&
Michael von Bergwelt-BaildonCologne Interventional Immunology, Department I of Internal Medicine, University of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany;Department of Medicine III, University Hospital, LMU Munich, Germany;Department of Otorhinolaryngology, Head and Neck Surgery, Georg August University, Goettingen, Germany;Partner Site, German Cancer Consortium (DKTK), Munich, Germany;German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
 show all
Article: 1535293 | Received 09 Feb 2018, Accepted 09 Oct 2018, Published online: 10 Jan 2019

References

  • Whiteside T. The role of regulatory T cells in cancer immunology. ImmunoTargets Ther. 2015;4:159. doi:10.2147/ITT.S55415.
  • Jie H-B, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP, Whiteside TL, Ferris RL. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. Br J Cancer. 2013;109:2629–2635. doi:10.1038/bjc.2013.623.
  • Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486–499. doi:10.1038/nri3862.
  • Ferris RL, Blumenschein G, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375:1856–1867. doi:10.1056/NEJMoa1602252.
  • Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008;14:5220–5227. doi:10.1158/1078-0432.CCR-08-0133.
  • Hennequin A, Derangère V, Boidot R, Apetoh L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L, et al. Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients. Oncoimmunology. 2016;5:e1054598. doi:10.1080/2162402X.2015.1054598.
  • Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejos Z, Gaudi I, Dobos J, Tímár J. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol Immunother. 2011;60:1729–1738. doi:10.1007/s00262-011-1011-9.
  • Berntsson J, Nodin B, Eberhard J, Micke P, Jirström K. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Int J Cancer. 2016;139:1129–1139. doi:10.1002/ijc.30138.
  • Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;9:292. doi:10.1186/1471-2407-9-292.
  • Lundgren S, Berntsson J, Nodin B, Micke P, Jirström K. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer. J Ovarian Res. 2016;9. doi:10.1186/s13048-016-0232-0.
  • Fremd C, Schuetz F, Sohn C, Beckhove P, Domschke C. B cell-regulated immune responses in tumor models and cancer patients. Oncoimmunology. 2013;2:e25443. doi:10.4161/onci.25443.
  • Affara NI, Ruffell B, Medler TR, Gunderson AJ, Johansson M, Bornstein S, Bergsland E, Steinhoff M, Li Y, Gong Q, et al. B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell. 2014;25:809–821. doi:10.1016/j.ccr.2014.04.026.
  • Shimabukuro-Vornhagen A, García-Márquez M, Fischer RN, Iltgen-Breburda J, Fiedler A, Wennhold K, Rappl G, Abken H, Lehmann C, Herling M, et al. Antigen-presenting human B cells are expanded in inflammatory conditions. J Leukoc Biol. 2017;101:577–587. doi:10.1189/jlb.5A0416-182R.
  • Wirsing AM, Rikardsen OG, Steigen SE, Uhlin-Hansen L, Hadler-Olsen E. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin Pathol. 2014;14:38. doi:10.1186/1472-6890-14-38.
  • Sautès-Fridman C, Lawand M, Giraldo NA, Kaplon H, Germain C, Fridman WH, Dieu-Nosjean M-C. Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention. Front Immunol. 2016;7:407. doi:10.3389/fimmu.2016.00407.
  • Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015;51:727–730. doi:10.1016/j.oraloncology.2015.03.015.
  • Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, Fučíková J, Truxová I, Tachezy R, Špíšek R, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570. doi:10.1080/2162402X.2015.1008371.
  • Broglie MA, Jochum W, Michel A, Waterboer T, Foerbs D, Schoenegg R, Stoeckli SJ, Pawlita M, Holzinger D. Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer. Oral Oncol. 2017;70:43–50. doi:10.1016/j.oraloncology.2017.05.010.
  • Atanackovic D, Blum I, Cao Y, Wenzel S, Bartels K, Faltz C, Hossfeld DK, Hegewisch-Becker S, Bokemeyer C, Leuwer R. Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma. Cancer Biol Ther. 2006;5:1218–1225.
  • Zamunér FT, Karia BTR, de Oliveira CZ, Dos Santos CR, Carvalho AL, Vettore AL. A comprehensive expression analysis of cancer testis antigens in head and neck squamous cell carcinoma revels MAGEA3/6 as a marker for recurrence. Mol Cancer Ther. 2015;14:828–834. doi:10.1158/1535-7163.MCT-14-0796.
  • Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I. Advances in human B cell phenotypic profiling. Front Immunol. 2012;3:1–15. doi:10.3389/fimmu.2012.00198.
  • Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129–140. doi:10.1016/j.immuni.2009.11.009.
  • Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E, Toubi E. Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev. 2012;11:670–677. doi:10.1016/j.autrev.2011.11.018.
  • Kaminski DA, Wei C, Rosenberg AF, Lee FE-H, Sanz I. Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus. Methods Mol Biol. 2012;900:109–134. doi:10.1007/978-1-60761-720-4_6.
  • Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42:607–612. doi:10.1016/j.immuni.2015.04.005.
  • Goc J, Fridman W-H, Sautès-Fridman C, Dieu-Nosjean M-C. Characteristics of tertiary lymphoid structures in primary cancers. Oncoimmunology. 2013;2:e26836. doi:10.4161/onci.26836.
  • Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189:832–844. doi:10.1164/rccm.201306-1150OC.
  • Deenick EK, Ma CS. The regulation and role of T follicular helper cells in immunity. Immunology. 2011;134:361–367. doi:10.1111/j.1365-2567.2011.03487.x.
  • Weber JP, Fuhrmann F, Feist RK, Lahmann A, Al Baz MS, Gentz L-J, Vu Van D, Mages HW, Haftmann C, Riedel R, et al. ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2. J Exp Med. 2015;212:217–233. doi:10.1084/jem.20141432.
  • Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010;11:535–542. doi:10.1038/ni.1877.
  • Slebos RJC, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:701–709. doi:10.1158/1078-0432.CCR-05-2017.
  • Näsman A, Andersson E, Nordfors C, Grün N, Johansson H, Munck-Wikland E, Massucci G, Dalianis T, Ramqvist T. MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome. Int J Cancer. 2013;132:72–81. doi:10.1002/ijc.v132.1.
  • Lechner A, Schlößer H, Rothschild SI, Thelen M, Reuter S, Zentis P, Shimabukuro-Vornhagen A, Theurich S, Wennhold K, Garcia-Marquez M, et al. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget. 2017;8:44418–44433. doi:10.18632/oncotarget.17901.
  • Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38:1074–1084. doi:10.1002/hed.24406.
  • Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, et al. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer. 2008;123:2626–2631. doi:10.1002/ijc.23837.
  • Russell S, Angell T, Lechner M, Liebertz D, Correa A, Sinha U, Kokot N, Epstein A. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol. 2013;5:24.
  • Distel LV, Fickenscher R, Dietel K, Hung A, Iro H, Zenk J, Nkenke E, Buttner M, Niedobitek G, Grabenbauer GG, et al. Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease. Oral Oncol. 2009;45:e167–74. doi:10.1016/j.oraloncology.2009.05.640.
  • Svensson MC, Warfvinge CF, Fristedt R, Hedner C, Borg D, Eberhard J, Micke P, Nodin B, Leandersson K, Jirström K. The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma. Oncotarget. 2017;8:72108–72126. doi:10.18632/oncotarget.v8i42.
  • Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, Spagnoli G, Ritter G, Hoffmann TK, Knuth A, et al. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer. Int J Cancer. 2014;135:1142–1152. doi:10.1002/ijc.28752.
  • Näsman A, Andersson E, Marklund L, Tertipis N, Hammarstedt-Nordenvall L, Attner P, Nyberg T, Masucci GV, Munck-Wikland E, Ramqvist T, et al. HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome. PLoS One. 2013;8:1–12. doi:10.1371/journal.pone.0077025.
  • Goeppert B, Frauenschuh L, Zucknick M, Roessler S, Mehrabi A, Hafezi M, Stenzinger A, Warth A, Pathil A, Renner M, et al. Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer. Br J Cancer. 2015;113:1343–1349. doi:10.1038/bjc.2015.337.
  • Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 2004;21:401–413. doi:10.1016/j.immuni.2004.06.017.
  • Stransky N, Egloff AM, Tward AD, Kostic AD, Sougnez C, Mckenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, et al. The mutational landscape of head squamous cell carcinoma. Science. 2011;333:1157–1160. doi:10.1126/science.1205623.
  • Bauer K, Michel S, Reuschenbach M, Nelius N, Von Knebel Doeberitz M, Kloor M. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Fam Cancer. 2011;10:557–565. doi:10.1007/s10689-011-9449-7.
  • Mansuet-Lupo A, Alifano M, Cuchet NP, Biton JR, Becht E, Goc J, Germain C, Ouakrim H, Gnard JFR, Cremer I, et al. Intratumoral immune cell densities are associated with lung adenocarcinoma gene alterations. Am J Respir Crit Care Med. 2016;194:1403–1412. doi:10.1164/rccm.201510-2031OC.
  • Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TFE, Beyer T, Reister F, Fabricius D, Lotfi R, et al. Interleukin 21–induced granzyme B–expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013;73:2468–2479.
  • Yuen GJ, Demissie E, Pillai S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2016;2:747–757. doi:10.1016/j.trecan.2016.10.010.
  • Zhou X, Su Y-X, Lao X-M, Liang Y-J, Liao G-Q. CD19+IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+Foxp3+ regulatory T cells. Oral Oncol. 2016;53:27–35. doi:10.1016/j.oraloncology.2015.11.003.
  • Huber U, Ziebart A, Schwarz S, Jerg M, Laban S, Hoffmann TK, Schuler P. 21 adenosine-producing B cells in patients with head and neck cancer. Oral Oncol. 2015;51:e34. doi:10.1016/j.oraloncology.2015.02.023.
  • Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG, et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell. 2010;17:121–134. doi:10.1016/j.ccr.2009.12.019.
  • Lohr M, Edlund K, Botling J, Hammad S, Hellwig B, Othman A, Berglund A, Lambe M, Holmberg L, Ekman S, et al. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Lett. 2013;333:222–228. doi:10.1016/j.canlet.2013.01.036.
  • DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, Varadarajan N, Giesecke C, Dörner T, Andrews SF, et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol. 2013;31:166–169. doi:10.1038/nbt.2595.
  • Franz B, May KF, Dranoff G, Wucherpfennig K. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. Blood. 2011;118:348–357. doi:10.1182/blood-2011-02-334870.
  • Correa I, Ilieva KM, Crescioli S, Lombardi S, Figini M, Cheung A, Spicer JF, Tutt ANJ, Nestle FO, Karagiannis P, et al. Evaluation of antigen-conjugated fluorescent beads to identify antigen-specific B cells. Front Immunol. 2018;9:493. doi:10.3389/fimmu.2018.00493.
  • Wennhold K, Thelen M, Schlößer HA, Haustein N, Reuter S, Garcia-Marquez M, Lechner A, Kobold S, Rataj F, Utermöhlen O, et al. Using antigen-specific B cells to combine antibody and T cell–based cancer immunotherapy. Cancer Immunol Res. 2017;5:730–743. doi:10.1158/2326-6066.CIR-16-0236.
  • Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Hoboken, NJ: Wiley-Blackwell; 2016.
  • Wieland U, Ritzkowsky A, Stoltidis M, Weissenborn S, Stark S, Ploner M, Majewski S, Jablonska S, Pfister HJ, Fuchs PG. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol. 2000;115:124–128. doi:10.1046/j.1523-1747.2000.00015.x.
  • Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, Getz G, Ally A, Balasundaram M, Birol I, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–582. doi:10.1038/nature14129.
  • Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36. doi:10.1186/gb-2013-14-4-r36.
  • R Development Core Team. R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria; 2011. http://www.R-project.org/.
  • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. doi:10.1186/gb-2004-5-10-r80.
  • Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R, Morgan MT, Carey VJ. Software for computing and annotating genomic ranges. PLoS Comput Biol. 2013;9:e1003118. doi:10.1371/journal.pcbi.1003118.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi:10.1186/s13059-014-0550-8.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
  • Wickham H. ggplot2: elegant graphics for data analysis. New York, NY: Springer; 2009.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.